The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme

Area of Science:

• Neuro-oncology
• Cancer biology
• Molecular medicine

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis despite standard treatments.
• Resistance to radiation therapy is a major challenge in GBM treatment.
• Identifying novel mediators of radioresistance is crucial for improving patient outcomes.

Purpose of the Study:

• To identify novel molecular targets that mediate radiation resistance in glioblastoma.
• To investigate the role of the immunoglobulin superfamily protein PTGFRN in GBM radioresistance and tumor growth.

Main Methods:

• Functional knockdown screen to identify genes involved in radiation resistance.
• Analysis of PTGFRN expression in GBM patient data.
• Assessment of PTGFRN inhibition effects on GBM cell radiosensitivity, proliferation, and tumor growth.
• Investigation of PTGFRN's impact on PI3K/AKT signaling and DNA damage repair pathways.

Main Results:

• PTGFRN is overexpressed in GBM and correlates with poor patient survival.
• Reducing PTGFRN expression radiosensitizes GBM cells, decreasing proliferation and tumor growth.
• PTGFRN inhibition leads to reduced PI3K p110β and phosphorylated AKT.
• PTGFRN inhibition impairs DNA damage sensing and repair by decreasing nuclear p110β.

Conclusions:

• Overexpression of PTGFRN promotes glioblastoma aggressiveness by enhancing AKT-driven survival and DNA repair.
• PTGFRN acts as a signaling hub contributing to radioresistance and tumor growth in GBM.
• PTGFRN inhibition represents a promising therapeutic strategy for overcoming GBM radioresistance.